Old Web
English
Sign In
Acemap
>
Paper
>
Risk of hypogammaglobulinemia in long-term treatment with rituximab in multiple sclerosis
Risk of hypogammaglobulinemia in long-term treatment with rituximab in multiple sclerosis
2019
S Hallberg
Malin Boremalm
B. Evertsson
E. Lillvall
F. Johansson
Jan Lycke
F. Piehl
Jonatan Salzer
Anders Svenningsson
Keywords:
Multiple sclerosis
Hypogammaglobulinemia
Physical therapy
Rituximab
long term treatment
Medicine
Pediatrics
Neurology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
9
Citations
NaN
KQI
[]